PTGS2 and polyp of colon: This may mean that the nonspecific cyclooxygenase inhibitors, such as sulindac and aspirin, may be more important agents in the prevention of colonic polyps, if compared to the Cox-2 specific inhibitors, such as celecoxib and rofecoxib, which are currently being studied in this context.